PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform.  PCI is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of cancer), fimaVACC (T-cell induction technology for therapeutic vaccination), and fimaNAC (nucleic acid therapeutics delivery).


Biotechnology

PCI Biotech

Kristin Eivindvik

Ronny Skuggedal

Anders Høgset

Morten Luhr

Hilde Furberg

Lars Viksmoen

Hans Peter Bøhn

Leadership Team

PCI Biotech

Org chart

Board & advisors

Teams

Leadership Team

Offices

Similar companies